Merck to buy Idenix for $3.85 billion
June 09, 2014 at 09:23 AM EDT
Deal is aimed at expanding Merck’s portfolio of Hepatitis C products
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.